![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 38, 35564-35570, September 21, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Biological Chemistry, Weizmann Institute of
Science, Rehovot 76100, Israel
Received for publication, June 6, 2001, and in revised form, July 10, 2001
G protein-coupled inwardly rectifying
K+ channels (GIRK) play a major role in inhibitory
signaling in excitable and endocrine tissues. The gating mechanism of
these channels is mediated by a direct interaction of the G G protein-coupled inwardly rectifying K+ channels
(GIRK)1 couple inhibitory
neurotransmission in brain, heart, and endocrine tissues to membrane
hyperpolarization. In the brain they are mainly responsible for the
generation of slow inhibitory postsynaptic potentials (1), and in the
heart they are involved in slowing of the heart rate in response to
vagal stimulation (2). The activation of GIRK channels by inhibitory
neurotransmission is triggered by the G Several studies have shown that redox signaling can serve as an
additional mechanism to modulate ion channel activity to link the
metabolic state of the cell to its electrical properties (for review
see Refs. 27 and 28). Redox signaling has been found to affect the
activity of several ion channels, such as the
N-methyl-D-aspartate receptor, NR1 (29), the
Ca2+-activated K+ channel, hslo (30),
ryanodine receptor (31), a voltage gated K+ channel, Kv1.4
(32), and the inwardly rectifying K+ channel, IRK1 (33). In
this study we examined the role of redox potential in mediating GIRK
channel activity expressed in Xenopus oocytes. Exposure of
GIRK channels to the membrane-permeable redox agent, dithiothreitol
(DTT), but not impermeable glutathione (GSH), increased channel
activity in a reversible manner when monitored under intact whole cell
conditions. This effect of DTT was specifically attributed to an
N-terminal cytosolic cysteine residue, as mutating this residue
abolished DTT action without affecting receptor-mediated channel
activation. In this study, we suggest that an increase of GIRK channel
activity by redox signaling can serve as a protective cellular
mechanism under hypoxic or ischemic insults.
Oocyte Preparation--
All channels and their mutants were
subcloned into pGEMHE expression vector (34). Oocytes were prepared as
described previously (14). Healthy-looking stage 5-6 oocytes were
selected and micro-injected with 50 nl of cRNA of the various channel
mutant cRNA alone (~0.1-5 ng) or with human m2 muscarinic receptor
(~.5 ng), G Site-directed Mutagenesis--
Site-directed mutagenesis was
done based on polymerase chain reaction of full-length plasmid using
the high fidelity Pfu polymerase (method by Stratagene).
Positive clones were verified by sequencing.
Electrophysiology--
Currents through the expressed channels
were recorded using the two-electrode voltage clamp technique as
previously described (14). Oocytes were held at 0 mV unless otherwise
indicated, and voltage ramps from
Single-channel currents were measured by the inside-out configuration
of the patch-clamp technique using an Axopatch 200B amplifier as
previously described (14). The pipette solution contained 140 mM KCl, 5 mM HEPES, 0.5 mM EGTA,
0.5 mM EDTA, pH 7.4. The FVPP bath solution contained 140 mM KCl, 10 mM HEPES, 10 mM EGTA, 10 mM
Na2H2P2O7, 5 mM NaF, 0.1 mM Na3VO4,
5 mM NaOH, pH 7.2, N-methyl-D-glucamine (NMG) (37). DTT and
GSH were diluted from 1 and 0.5 M stock solutions,
respectively, before use.
Statistical and Data Analysis--
Data are presented as fold
induction means ± S.E., and n denotes the number of
oocytes assayed. A t test was used to calculate the
statistical significance of differences between different populations.
We were interested in testing the effect of the reducing agent,
DTT, on GIRK1/4 channel function. Two electrode voltage clamp recordings of Xenopus oocytes expressing GIRK1 and GIRK4
display inwardly rectifying currents upon application of voltage ramp protocols from We also wanted to test whether the effect seen with DTT on GIRK1/4
channel currents was specific for the GIRK family. We therefore tested
the effect of DTT using the same protocols as above on the G
protein-independent inwardly rectifying K+ channel, IRK1.
DTT had no stimulatory effect on the IRK1 currents but, rather, induced
a slight inhibition 0.79 ± 0.17- fold (n = 6)
(Fig. 1D). The decrease in IRK1 currents by DTT has been seen before by Ruppersberg et al. (33). We then tested
whether the DTT effect depends on soluble components endogenously
present in the oocyte cytosol.
To further verify that the lack of GSH to induce channel activity was
due to its inability to cross the plasma membrane, we performed single
channel recordings on excised inside-out patches and tested the effect
of 1 mM DTT or 10 mM GSH applied to the cytosolic face of the patch. Extensive washes of the inner face of the
patches did not abolish the DTT or the GSH effect. Both DTT and GSH
increased the probability of channel openings without affecting the
single channel amplitude measured at
Redox-dependent Gating of G Protein-coupled Inwardly
Rectifying K+ Channels*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

subunits of G protein, which are released upon inhibitory
neurotransmitter receptor activation. This gating mechanism is further
manifested by intracellular factors such as anionic phospholipids and
Na+ and Mg2+ ions. In addition to the essential
role of these components for channel function, phosphorylation events
can also modulate channel activity. In this study we explored the
involvement of redox modulation on GIRK channel function. Extracellular
application of the reducing agent dithiothreitol (DTT), but not reduced
glutathione, activated GIRK channels without affecting their permeation
or rectification properties. The DTT-dependent activation
was found to mimic receptor activation and to act directly on the
channel in a membrane delimited fashion. A critical cysteine residue
located in the N-terminal cytoplasmic domain was found to be essential
for DTT-dependent activation in hetero- and homotetrameric
contexts. Interestingly, when mutating this cysteine residue,
DTT-dependent activation was abolished, but
receptor-mediated channel activation was not affected. These results
suggest that intracellular redox potential can play a major role in
tuning GIRK channel activity in a receptor-independent manner. This
sort of redox modulation can be part of an important cellular
protective mechanism against ischemic or hypoxic insults.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

subunits of the G protein
(3-5). This G
-channel interaction involves binding of G
to
both the N- and C-terminal cytoplasmic domains (6-12), which appears
to drive a rearrangement of the pore-forming second transmembrane
-helix (TM2) to open the channel (13, 14). The G
-mediated
gating of the channel can be aided by other intracellular components.
Sodium and Mg2+ ions have been found to interact with the
C-terminal cytoplasmic domain of the channel to fine-tune channel
gating mediated by the anionic phospholipid,
phosphatidylinositol-4,5-bisphosphate (15-19), which is an obligatory
component for the stability of the open state of the channel (14). The
Na+-phosphatidylinositol-4,5-bisphosphate interaction can
also serve as a mechanism for modulating by external ligands (20). In
addition to the modulatory action of the various ionic species
mentioned above, channel function can also be tuned by
phosphorylation/dephosphorylation events. Activation of TrkB receptors
by neurotrophin brain-derived neurotrophic factor affects channel
function via tyrosine phosphorylation (21), and activation of cAMP
formation via
2-adrenergic receptors facilitates channel function
(22). These phosphorylation events may act by affecting the interaction
of the G
subunits with the channel by occluding the G
binding site (23). Additionally, inhibitory signaling can occur via
protein kinase C modulation by an as yet unknown mechanism
(24-26).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1
2 (~1 ng each), c
ARK
(C-terminus of
-adrenergic receptor kinase, ~1 ng) (35), or PTX-S1
(36) (~1 ng). All recordings were made 3-14 days post-injection.
100 mV to +50 mV for 0.6 s
were applied. The oocytes were washed for at least 2 min with 90K
solution containing 90 mM KCl, 10 mM HEPES,
2 mM MgCl2, pH 7.4 (KOH) before data
collection. In all experiments presented, oocytes expressing less than
10 µA of current at
100 mV were used.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
100 to +50 mV. Upon the application of 10 mM DTT to the extracellular solution in the absence of
expressed G protein coupled receptors and agonists of native receptors,
a gradual increase in basal inwardly rectifying current is apparent
that reaches a maximum steady state induction within 10 min of
application and reverses upon DTT washout to base-line levels (Fig.
1, A and B). The
average induction of GIRK1/4 channel currents was 2.62 ± 0.20-fold (n = 12) (Fig. 1C). The
DTT-induced currents did not change the rectification characteristics
monitored at +50 mV (Fig. 1, A and B) and did not
change ion selectivity (K+ versus
Na+, data not shown). Thus, these results suggest that the
selective increase in membrane current by DTT is mainly due to an
increase in activity of GIRK1/4 channels. In control experiments, DTT
had no effect on uninjected oocyte basal current levels. To assess the
dose dependence of DTT action on GIRK1/4 channel currents, we measured
current levels in response to a series of DTT solutions of increasing
concentrations. We found that the DTT concentration that induced 50%
of the maximal increase in basal GIRK1/4 currents was 1.93 ± 0.89 mM, with a Hill coefficient of 0.84 ± 0.32 (Fig. 1D). To test whether DTT action is intracellular, we also
tested the effect of the non-permeant reducing agent GSH on channel
currents. GSH, at 10 mM, did not induce an increase in
current (0.68 ± 0.05-fold (n = 6) induction),
suggesting that the action site of DTT is intracellular (Fig.
1C).

View larger version (22K):
[in a new window]
Fig. 1.
DTT activates GIRK channels expressed in
Xenopus oocytes in a membrane-delimited manner.
A, time course of GIRK current induction by 10 mM DTT applied to the extracellular solution for 10 min and
the return to basal current levels after washout. Current levels at +50
and
50 mV were taken from ramps (
100 to +50 mV for 1 s)
applied every 2 s from a holding potential of 0 mV. B,
representative ramps before (1), during (2), and
after (3) induction by DTT. Ramps were taken at the
indicated times marked by the numbered arrows in
A. C, bar graph summarizing the effect
of DTT and GSH on GIRK1/4 and the effect of DTT on IRK1 channel
currents. D, cumulative dose response curve for DTT
induction of GIRK1/4 channels. GIRK1/4 steady state induction was
normalized to the induction achieved by 30 mM DTT at the
end of a 10-min application. Points were fitted to the Hill equation
with EC50 for DTT induction of 1.93 ± 0.89 mM.
100 mV (Fig. 2, A and B).
Interestingly, extensive washout (for at least 5 min) was not able to
reverse either the DTT or the GSH effects, and the channels remained as
active as in the presence of the corresponding reducing agent. Thus,
these results suggest that the action of DTT to induce channel
activation is membrane-delimited, and the reversibility of this effect
(as seen under whole cell measurements, Fig. 1A) may depend
on the cytoplasmic factor(s) that is absent in the excised patch.

View larger version (54K):
[in a new window]
Fig. 2.
Both DTT and GSH are able to activate GIRK1/4
channel when applied to the cytoplasmic side of the membrane.
Single channel current traces under excised patch condition in the
absence (left) and in the presence of 1 mM
DTT (A) and 10 mM GSH (B) and
following extensive washout (right). Current traces are
shown in two different time scales (above 1 min and below 1.2 s/trace).
These patches were held at
100 mV and contained at least three
channels.
In native tissue, GIRK1/4 channels are activated by
neurotransmitter receptor stimulation, and so we were interested in
examining the nature of DTT channel induction in relation to activation by the type 2 muscarinic receptor (m2R). Oocytes were co-injected with
GIRK1/4 channel and m2R, and the effect of DTT was tested in the
presence and absence of receptor stimulation using 3 µM carbachol. Receptor-mediated channel activity was measured after 30 s of application of carbachol in the presence and in the
absence of 10 mM DTT (Fig.
3A). Carbachol application
alone increased the GIRK1/4 currents by 6.6 ± 0.7-fold
(n = 8), and carbachol application in addition to DTT
increased the current by 6.7 ± 0.5-fold (Fig. 3B).
This indicates that DTT induction of the GIRK1/4 channel is not
additive to receptor stimulation and, thus, may act on the same
activation pathway or on a converged one. To further explore this
possibility, we tested whether DTT is able to induce channel currents
once channels are fully activated, independent of receptor stimulation.
One way to fully activate the channels is by the co-expression of the
channel with the G
1
2 subunits of the G
protein (4). Application of 10 mM DTT to oocytes
co-expressing GIRK1/4 channels and G
1
2
induced an increase in currents with 1.34 ± 0.11-fold
(n = 5) induction (Fig.
4A), but as with receptor stimulation, this effect was occluded in that it was considerably smaller that the 2.6-fold induction seen in the absence of G
. An
alternate way to test the effect of DTT on fully activated GIRK1/4
channels is to use constitutively active, G
-independent channel
mutants (14). These mutations, localized to the TM2 domain of the
channel, lock the channel in its activated conformation. We tested two
of these mutants, GIRK1(C179A)/GIRK4(C185A) and GIRK1(S170P)/GIRK4(S176P). Once again, DTT had a considerably attenuated induction of channel currents, with 1.24 ± 0.06 (n = 5) and 1.19 ± 0.07-fold (n = 8) induction for the two mutants, respectively (Fig. 4A).
The reduced ability of DTT to induce channel activity in activated
channels suggests that the action of DTT may be to mimic
G
-dependent activation.
|
|
Two possibilities are likely to explain the above results. The action
of DTT could be the consequence of direct reduction of the channel, and
the second possibility involves DTT activation of either the G protein
trimers to release G
or of another second messenger system. To
address the latter possibility, we tested the ability of DTT to induce
channel currents under three different conditions that reduce the
levels of free G
in the oocyte. The first way was by
co-expressing the catalytic subunits of pertussis toxin
(PTX-S1). PTX-S1 induces ADP-mediated ribosylation of the G
i/o subunit of the G protein and prevents the release
of G
. The second way to reduce free G
levels in the oocyte
was by expressing the C-terminal end of the
-adrenergic receptor
kinase (C-
ARK), which has been shown to bind the G
subunits of
G proteins (38) and, thus, to reduce channel activity (4). The third way to reduce G
levels was by the co-expression of
G
s, with the idea that an excess of G
s
will act as a large sink for free G
subunits (39). As expected,
under the first two conditions, m2R activation was impaired (Fig.
4C). However, the DTT induction was not significantly
affected (Fig. 4B). DTT induction for co-expression with
PTX-S1, C-
ARK (C-terminal end of the
-adrenergic receptor kinase), or G
s was 2.2 ± 0.2, 1.9 ± 0.3, and
2.9 ± 0.8-fold, respectively. These results suggest that DTT
activates GIRK1/4 channels without a direct activation of G proteins.
As discussed above, protein kinases may regulate GIRK channel activity. To rule out any involvement of protein kinase A or protein kinase C in DTT action, we used the potent nonspecific protein kinase inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride (H7). Oocytes expressing GIRK1/4 channels were incubated in 100 µM H7 for at least 20 min before recordings, and the action of DTT was then tested. Incubation with H7 failed to affect DTT stimulatory action, with DTT induction of 2 ± 0.3-fold. These results suggest that the action of DTT on the channel is not mediated through the activation of protein kinase A or protein kinase C in the oocytes.
Recently, it has become evident that many proteins undergo specific post-translational modification on cysteine residues, mainly by the use of nitric oxide donors, to form nitrosylated cysteines (for review, see ref. 40). Thus, another possible target for DTT action is the breakdown of a nitrosylated cysteine that participates in channel regulation. We explored this possibility using two independent approaches to modify nitric oxide levels; those approaches were either by using a nitrosothiol derivative that releases nitric oxide, S-nitroso-N-acetylpenicillamine, or by direct inhibition of nitric oxide synthase using NG-nitro-L-arginine methyl ester. These compounds had no affect on channel function, receptor activation, or basal channel activity (not shown). In addition, it is also worth noting that the critical negative residue essential for the acid-base catalysis of sulfahydryl nitrosylation, which should flank potential nitrosylated cysteines, is not present around cysteines in either GIRK1 or GIRK4 (41). These results thus suggest that GIRK channels are not regulated by nitrosylation, and the effect of DTT is probably not mediated through this pathway.
The above results suggest that DTT may mediate channel induction via
direct reduction of cytoplasmic cysteines of the channel molecule.
GIRK1 and GIRK4 contain seven and eight cysteine residues, respectively, including two extracellular conserved residues at positions 123 and 156 in GIRK1 and at positions 129 and 162 in GIRK4.
These cysteines are fully conserved in all inwardly rectifying K+ channels and have been shown to be important for the
assembly of IRK-like channels (42-44). There is an additional cysteine
located in the TM2 domain that is conserved in all members of the GIRK and K-ATP channel families. This cysteine has been shown to be involved
in G
-mediated gating conformation (14). Alignment of the Kir
family members reveals another conserved residue at the intracellular N
terminus of the channel, at positions 53 and 60 in GIRK1 and GIRK4,
respectively. The remaining intracellular cysteines are located in the
C-terminal cytosolic domain of the channel (Fig.
5A). All six GIRK4
intracellular cysteines were replaced, and the channel mutants were
co-expressed with wild type GIRK1 channel. We found that none of the
single cysteine substitutions affected the ability of DTT to induce
channel currents (Fig. 5B). The following GIRK4 mutants
co-expressed with GIRK1 were induced by DTT by: C60A, 1.98 ± 0.20 (n = 5)-fold; C216A, 3.32 ± 0.66 (n = 5)-fold; C316T, 1.85 ± 0.18 (n = 5)-fold; C362A + C363S, 1.84 ± 0.11 (n = 5)-fold; C389A, 1.86 ± .07 (n = 5)-fold (Fig. 5C).
|
Since removing individual cysteines from GIRK4 in the heteromultimeric
context was not sufficient to affect DDT action, we wanted to test
whether removing all intracellular cysteines in a homomultimeric
context would have an effect. To simplify the possible mutant
combinations we used a GIRK4 mutant, GIRK4(S143T), that has been shown
to form functional homotetramers (36) and tested the ability of DTT to
induce its currents. Fig. 6A
represents a time course of DTT induction of the GIRK4(S143T) channel.
DTT was able to induce GIRK4(S143T) channel currents in a similar manner to the GIRK1/4 heteromultimer with 2.3 ± 0.3-fold
induction. We then removed all intracellular cysteines in the
background of the S143T mutation and tested the effect of DTT (Fig.
6B). DTT failed to affect the homomeric GIRK4(S143T),
lacking all six intracellular cysteines (C60A, C216A, C316T, C362A,
C363S, and C389A), with 0.8 ± 0.23-fold induction (Fig.
6D), without affecting m2R activated currents (Fig.
6C). This first suggests that the action of DTT on induction
of channel currents is probably mediated through the channel
intracellular cysteines and, second, that the mechanism by which DTT
induces activity and receptor-mediated activation are via two separate
pathways.
|
We set out to identify the cysteine residue responsible for DTT
induction in the homomeric GIRK4(S143T) context. We therefore mutated
all intracellular cysteines in groups according to their location in
the linear sequence of the channel. All channel mutants that contained
the C60A mutation failed to respond to DTT (Fig. 6D). Thus,
these results suggest that the cysteine residue at position C60 is
involved in channel activation by DTT. Since in native tissues most of
the GIRK channel combinations form heteromultimers, we also wanted to
test whether mutating the analogous cysteines at position Cys-53 and
Cys-60 in GIRK1 and GIRK4, respectively, would affect DTT induction.
GIRK1(C53A)/GIRK4(C60A) mutant channels failed to respond to DTT, as
seen in the homomultimeric context (Fig.
7A), without affecting the
ability of carbachol to induce currents (Fig. 7B). These
results again suggest that the N-terminal cysteines at positions Cys-53
and Cys-60 in GIRK1 and GIRK4, respectively, play a critical role in
DTT action without affecting receptor-mediated activation.
|
| |
DISCUSSION |
|---|
|
|
|---|
In this paper, we report a novel mechanism to modulate GIRK
channel gating; that is, reduction of a conserved cysteine residue in
the N-terminal cytosolic domain. This form of gating may operate in
parallel to the action of the classical activators of the channel, the
G
subunits of the G protein, phospholipids and Na+
ions. From the experiments presented above we suggest that reduction by
DTT mimics gating of the channel by G
subunits. Several lines of
evidence contribute to this conclusion. First, GIRK currents are
activated by DTT without a change in rectification and selectivity. Second, the effect of DTT is reduced with receptor-mediated GIRK channel activation and with the constitutive activation caused by
overexpressing G
1
2. Third, channels that
are constitutively active and G
-independent (14) abolish the
DTT-mediated induction. These results may suggest that the cysteine
reduction mechanism involves a similar conformation of the gating
apparatus as induced by receptor stimulation or the G
subunits
but, interestingly, without affecting channel rectification.
The failure of DTT to affect channel rectification is the most apparent
difference in channel biophysical properties between activation by
receptor stimulation and DTT. In the former case, the extent of channel
rectification during activation is reduced, and hence, more current is
apparent at potentials above the equilibrium for K+ ions
(for example, see Fig. 3A traces at +50 mV). In the latter situation, DTT activation gating does not affect channel rectification. One plausible explanation for this difference is that DTT opens GIRK1/4
channels to a state where the gate is open but does not undergo an
additional transition normally induced by a full
receptor-dependent activation. This full transition gating
state induced by receptor stimulation of the channel may suggest that
G
interaction, unlike DTT induction, affects channel conformation
by reducing the binding of either Mg2+ ions or polyamines.
This may be due to the ability of G
to strongly interact
with the C-terminal cytoplasmic domain of the channel and
induce a conformational change in the second transmembrane domain of
the channel (13, 14). These two regions are known to interact with the
components responsible for inward rectification, Mg2+ ions
and polyamines (Ref. 45 and 46; for review, see also Ref. 47). The
robust capacity of G
to gate the channel compared with DTT is
also evident by the ~2-fold less efficient channel activation by
DTT.
Does DTT directly act on the channel molecule, or is its action
mediated via a second mediator? Such mediated action could involve DTT
activation of the G protein-coupled receptor, the G protein, or of
another second-messenger system. First, we can exclude the possibility
that DTT acts directly on the G protein-coupled receptor (48) because
1) the effect of DTT was seen with oocytes expressing only the GIRK
channel, without the m2R receptor, and 2) co-expression of the channel
and the receptor with the catalytic subunit of pertussis toxin
abolished receptor-mediated activation (36) but did not affect the
ability of DTT to induce channel currents. Second, we can also exclude
the possibility that DTT directly activates the G protein trimer to
release G
subunits. This is because co-expression of the GIRK
channel with either G
s or the C terminus of
ARK, both
of which reduce the availability of free G
(35, 39), did not
affect DDT induction, even though it dramatically reduced
receptor-mediated activation. This indicates that DTT-mediated channel
induction does not involve a direct activation of G proteins in the
oocyte. Third, we can also exclude the involvement of protein
kinase activation by DTT, since the nonspecific kinase inhibitor, H7,
was unable to abolish DTT induction, and fourth, we can exclude the
involvement of nitrosylation in DTT action. We therefore can suggest
that DTT action is a direct effect on the channel molecule to induce an
activated conformation.
The proposal that the DTT effect on GIRK gating is direct is further
supported by the finding that the DTT effect is eliminated by removal
of all of the intracellular cysteines from the GIRK4(S143T) homomultimeric channel. By systematically eliminating individual cysteines from this homomeric channel, it becomes apparent that only
the N-terminal cytosolic cysteine at position 60 is essential for
DTT-mediated activation. Moreover, from experiments using co-expression of GIRK1 wild type and GIRK4(C60A) mutant channels, it is
apparent that it is not obligatory to have N-terminal cysteines in all
four channel subunits for DTT to gate the channel (Fig. 5C).
Since experiments involving tandemly linked different GIRK channel
subunits point toward a specific preferred architecture of functional
channels, alternating GIRK1/GIRK4 monomers (49, 50), it becomes
plausible to conclude that N-terminal cysteines from neighboring
subunits are not involved in DTT action. Once the N-terminal cysteines
are removed from both subunits, GIRK1(C53A) and GIRK4(C60A), DTT is no
longer able to activate the channel. Thus, if indeed the action of DTT
is to mediate the reduction of disulfide bridges, they should exist
between diagonal subunits, which will require the opposing N-terminal
cytosolic domains to be within a few angstroms of each other, as the
length between two thio groups forming disulfide bond is about 2 Å. Alternatively, the N-terminal cysteines can be oxidized at
their sulfhydryl group (at physiological pH) to become reactive
cysteines (thiolate, S
). This reactivity can be
stabilized by positively charged amino acids neighboring these
cysteines, as seen in the bacterial transcription factor OxyR (51).
Interestingly, in the GIRK channel family, there is a lysine side chain
immediately preceding the N-terminal cysteines, which is not found in
the IRK channel family. These reactive cysteines can form sulfenic ion
(S-OH) under very mild oxidation that can cause them to interact with
the high levels of intracellular GSH to form mixed disulfides (28). Due
to the lower reducing potential of DTT compared with GSH, DTT may act to reduce this mixed disulfide to the sulfhydryl form. The equilibrium between the mixed disulfide and sulfhydryl or reactive cysteine species
may determine the receptor-independent activity of the channel. The
fact that DTT induction is reversible only under intact whole cell and
not under excised patch configuration suggests that cytosolic factors,
e.g. thioredoxin or glutaredoxin, may be involved in the
reversal of DTT induction. We thus hypothesize that the cysteines in
the N-terminal cytoplasmic domain of the channel can undergo an
oxidation-reduction cycle to modulate channel activity.
What is the physiological relevance of redox-mediated GIRK channel
activation? In the past few years it has become more appreciated that
redox signaling at low concentrations of reactive oxygens may play a
major role in regulating many cellular events such as cell-cell
adhesion, immunological responses, and cellular excitability (for
review, see Refs. 52 and 53). Under hypoxic or ischemic conditions,
when the oxygen tension is reduced, activation of GIRK channels may be
of great importance, specifically in reducing cellular excitability by
hyperpolarization. For example, in CA1 pyramidal neurons hypoxia causes
hyperpolarization, which is independent of opening of K-ATP,
Ca2+-activated K+ or Cl
channels
(54). This form of GIRK channel control by redox modulation can serve
as a control to reduce excitability independent of synaptic activity.
In the case of the heart it has been proposed that ischemic preconditioning, a protective mechanism in which a brief period of
myocardial ischemia renders the myocardium resistant to a more sever
ischemic insult (55), is mediated by a pertussis
toxin-sensitive mechanism that involves acetylcholine and adenosine
(56). Although most of the published observations point toward the
involvement of mitochondrial K-ATP channels in this protection during
preconditioning ischemic insults (57), it is interesting to note that
both neurotransmitters also activate GIRK channels in atrial myocytes.
This relation raises the possible involvement of GIRK channels in this
protective action, specifically the anti-arrhythmic aspect of preconditioning.
In summary, the present work identifies a novel aspect of GIRK channel
gating in which the redox state can modulate channel gating. An
increase in redox potential opens the GIRK channel without affecting
the permeation properties of the channel. We identify a single
conserved residue located in the N terminus of the channel as the main
mediator of this action. This redox-dependent gating is an
additional gating mechanism to neurotransmitter-receptor activation,
which underlies its importance as a potential protective mechanism in
cases of ischemic or hypoxic shock, mainly by membrane hyperpolarization to reduce cellular excitability.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. A. Danon for helpful discussions, Dr. E. Y. Isacoff and N. Alagem for reading the manuscript and for discussions, and R. Meller and E. Shalgi for excellent technical assistance.
| |
FOOTNOTES |
|---|
* This work was supported by the Israeli Science Foundation, the Minerva Foundation (Germany), the Human Frontier Science Program, and the Buddy Taub Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 972-8-934-3243;
Fax: 972-8-934-2135; E-mail: e.reuveny@weizmann.ac.il.
Published, JBC Papers in Press, July 20, 2001, DOI 10.1074/jbc.M105189200
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
GIRK, G
protein-coupled inwardly rectifying potassium channels;
G
, G
protein
and
subunits;
DTT, dithiothreitol;
TM2, second
transmembrane
-helix;
IRK1, inward rectifier type Kir2.1;
PTX-S1, catalytic subunits of pertussis toxin;
m2R, type 2 muscarinic receptor.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Luscher, C., Jan, L. Y., Stoffer, M., Malenka, R. C., and Nicoll, R. A. (1997) Neuron 19, 687-695 |
| 2. | Wickman, K., Nemec, J., Gendler, S. J., and Clapham, D. E. (1998) Neuron 20, 103-114 |
| 3. | Logothetis, D. E., Kurachi, Y., Galper, J., Neer, E. J., and Clapham, D. E. (1987) Nature 325, 321-326 |
| 4. | Reuveny, E., Slesinger, P. A., Inglese, J., Morales, J. M., Iniguez-Lluhi, J. A., Lefkowitz, R. J., Bourne, H. R., Jan, Y. N., and Jan, L. Y. (1994) Nature 370, 143-146 |
| 5. | Wickman, K. D., Iniguez-Lluhl, J. A., Davenport, P. A., Taussig, R., Krapivinsky, G. B., Linder, M. E., Gilman, A. G., and Clapham, D. E. (1994) Nature 368, 255-257 |
| 6. | Huang, C. L., Jan, Y. N., and Jan, L. Y. (1997) FEBS Lett. 405, 291-298 |
| 7. | Huang, C. L., Slesinger, P. A., Casey, P. J., Jan, Y. N., and Jan, L. Y. (1995) Neuron 15, 1133-1143 |
| 8. | Inanobe, A., Morishige, K. I., Takahashi, N., Ito, H., Yamada, M., Takumi, T., Nishina, H., Takahashi, K., Kanaho, Y., Katada, T., and Kurachi, Y. (1995) Biochem. Biophys. Res. Commun. 212, 1022-1028 |
| 9. | Krapivinsky, G., Krapivinsky, L., Wickman, K., and Clapham, D. E. (1995) J. Biol. Chem. 270, 29059-29062 |
| 10. | Kunkel, M. T., and Peralta, E. G. (1995) Cell 83, 443-449 |
| 11. | Slesinger, P. A., Reuveny, E., Jan, Y. N., and Jan, L. Y. (1995) Neuron 15, 1145-1156 |
| 12. | He, C., Zhang, H., Mirshahi, T., and Logothetis, D. E. (1999) J. Biol. Chem. 274, 12517-12524 |
| 13. | Yi, B. A., Lin, Y., Jan, Y. N., and Jan, L. Y. (2001) Neuron 29, 657-667 |
| 14. | Sadja, R., Smadja, K., Alagem, N., and Reuveny, E. (2001) Neuron 29, 669-680 |
| 15. | Petit-Jacques, J., Sui, J. L., and Logothetis, D. E. (1999) J. Gen. Physiol. 114, 673-684 |
| 16. | Zhang, H., He, C., Yan, X., Mirshahi, T., and Logothetis, D. E. (1999) Nat. Cell Biol. 1, 183-188 |
| 17. | Sui, J. L., Chan, K. W., and Logothetis, D. E. (1996) J Gen Physiol 108, 381-391 |
| 18. | Sui, J. L., Petit-Jacques, J., and Logothetis, D. E. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 1307-1312 |
| 19. | Lesage, F., Guillemare, E., Fink, M., Duprat, F., Heurteaux, C., Fosset, M., Romey, G., Barhanin, J., and Lazdunski, M. (1995) J. Biol. Chem. 270, 28660-28667 |
| 20. | Rogalski, S. L., and Chavkin, C. (2001) J. Biol. Chem. 276, 14855-14860 |
| 21. | Rogalski, S. L., Appleyard, S. M., Pattillo, A., Terman, G. W., and Chavkin, C. (2000) J. Biol. Chem. 275, 25082-25088 |
| 22. | Mullner, C., Vorobiov, D., Bera, A. K., Uezono, Y., Yakubovich, D., Frohnwieser-Steinecker, B., Dascal, N., and Schreibmayer, W. (2000) J. Gen. Physiol. 115, 547-558 |
| 23. | Medina, I., Krapivinsky, G., Arnold, S., Kovoor, P., Krapivinsky, L., and Clapham, D. E. (2000) J. Biol. Chem. 275, 29709-29716 |
| 24. | Vorobiov, D., Levin, G., Lotan, I., and Dascal, N. (1998) Pfluegers Arch. Eur. J. Physiol. 436, 56-68 |
| 25. | Sharon, D., Vorobiov, D., and Dascal, N. (1997) J. Gen. Physiol. 109, 477-490 |
| 26. | Mark, M. D., Ruppersberg, J. P., and Herlitze, S. (2000) Neuropharmacology 39, 2360-2373 |
| 27. | Peers, C. (1997) Trends Pharmacol. Sci. 18, 405-408 |
| 28. | Finkel, T. (2000) FEBS Lett. 476, 52-54 |
| 29. | Sullivan, J. M., Traynelis, S. F., Chen, H. S., Escobar, W., Heinemann, S. F., and Lipton, S. A. (1994) Neuron 13, 929-936 |
| 30. | DiChiara, T. J., and Reinhart, P. H. (1997) J. Neurosci. 17, 4942-4955 |
| 31. | Haarmann, C. S., Fink, R. H., and Dulhunty, A. F. (1999) Biophys. J. 77, 3010-3022 |
| 32. | Ruppersberg, J. P., Stocker, M., Pongs, O., Heinemann, S. H., Frank, R., and Koenen, M. (1991) Nature 352, 711-714 |
| 33. | Ruppersberg, J. P., and Fakler, B. (1996) Neuropharmacology 35, 887-893 |
| 34. | Liman, E. R., Tytgat, J., and Hess, P. (1992) Neuron 9, 861-871 |
| 35. | Jing, J., Chikvashvili, D., Singer-Lahat, D., Thornhill, W. B., Reuveny, E., and Lotan, I. (1999) EMBO J. 18, 1245-1256 |
| 36. | Vivaudou, M., Chan, K. W., Sui, J. L., Jan, L. Y., Reuveny, E., and Logothetis, D. E. (1997) J. Biol. Chem. 272, 31553-31560 |
| 37. | Huang, C. L., Feng, S., and Hilgemann, D. W. (1998) Nature 391, 803-806 |
| 38. | Pitcher, J. A., Inglese, J., Higgins, J. B., Arriza, J. L., Casey, P. J., Kim, C., Benovic, J. L., Kwatra, M. M., Caron, M. G., and Lefkowitz, R. J. (1992) Science 257, 1264-1267 |
| 39. | Lim, N. F., Dascal, N., Labarca, C., Davidson, N., and Lester, H. A. (1995) J. Gen. Physiol. 105, 421-439 |
| 40. | Stamler, J. S., and Meissner, G. (2001) Physiol. Rev. 81, 209-237 |
| 41. | Stamler, J. S., Toone, E. J., Lipton, S. A., and Sucher, N. J. (1997) Neuron 18, 691-696 |
| 42. | Bannister, J. P., Young, B. A., Sivaprasadarao, A., and Wray, D. (1999) FEBS Lett. 458, 393-399 |
| 43. | Cho, H. C., Tsushima, R. G., Nguyen, T. T., Guy, H. R., and Backx, P. H. (2000) Biochemistry 39, 4649-4657 |
| 44. | Leyland, M. L., Dart, C., Spencer, P. J., Sutcliffe, M. J., and Stanfield, P. R. (1999) Pfluegers Arch. Eur. J. Physiol. 438, 778-781 |
| 45. | Kubo, Y., and Murata, Y. (2001) J. Physiol. 531, 645-660 |
| 46. | Yang, J., Jan, Y. N., and Jan, L. Y. (1995) Neuron 14, 1047-1054 |
| 47. | Nichols, C. G., and Lopatin, A. N. (1997) Annu. Rev. Physiol. 59, 171-191 |
| 48. | Pedersen, S. E., and Ross, E. M. (1985) J. Biol. Chem. 260, 14150-14157 |
| 49. | Silverman, S. K., Lester, H. A., and Dougherty, D. A. (1996) J. Biol. Chem. 271, 30524-30528 |
| 50. | Tucker, S. J., Pessia, M., and Adelman, J. P. (1996) Am. J. Physiol. 271, H379-H385 |
| 51. | Zheng, M., Aslund, F., and Storz, G. (1998) Science 279, 1718-1721 |
| 52. | Sen, C. K. (1998) Biochem. Pharmacol. 55, 1747-1758 |
| 53. | Kourie, J. I. (1998) Am. J. Physiol. 275, C1-C24 |
| 54. | Hyllienmark, L., and Brismar, T. (1999) Neuroscience 91, 511-517 |
| 55. | Murry, C. E., Jennings, R. B., and Reimer, K. A. (1986) Circulation 74, 1124-1136 |
| 56. | Schultz, J. E., Hsu, A. K., Barbieri, J. T., Li, P. L., and Gross, G. J. (1998) Am. J. Physiol. 275, H495-H500 |
| 57. | Cohen, M. V., Baines, C. P., and Downey, J. M. (2000) Annu. Rev. Physiol. 62, 79-109 |
This article has been cited by other articles:
![]() |
L.-M. Fan, W. Zhang, J.-G. Chen, J. P. Taylor, A. M. Jones, and S. M. Assmann Abscisic acid regulation of guard-cell K+ and anion channels in G{beta}- and RGS-deficient Arabidopsis lines PNAS, June 17, 2008; 105(24): 8476 - 8481. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hinzpeter, J. Fritsch, F. Borot, S. Trudel, D.-L. Vieu, F. Brouillard, M. Baudouin-Legros, J. Clain, A. Edelman, and M. Ollero Membrane Cholesterol Content Modulates ClC-2 Gating and Sensitivity to Oxidative Stress J. Biol. Chem., January 26, 2007; 282(4): 2423 - 2432. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, W.-P. Yu, C.-W. Lin, and T.-Y. Chen Oxidation and Reduction Control of the Inactivation Gating of Torpedo ClC-0 Chloride Channels Biophys. J., June 1, 2005; 88(6): 3936 - 3945. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Flynn and W. N. Zagotta A Cysteine Scan of the Inner Vestibule of Cyclic Nucleotide-gated Channels Reveals Architecture and Rearrangement of the Pore J. Gen. Physiol., May 27, 2003; 121(6): 563 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mao, J. Wu, F. Chen, X. Wang, and C. Jiang Inhibition of G-protein-coupled Inward Rectifying K+ Channels by Intracellular Acidosis J. Biol. Chem., February 21, 2003; 278(9): 7091 - 7098. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Guo, G. J. Waldron, and R. Murrell-Lagnado A Role for the Middle C Terminus of G-protein-activated Inward Rectifier Potassium Channels in Regulating Gating J. Biol. Chem., December 6, 2002; 277(50): 48289 - 48294. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Cai, K. Zhang, and J. Lytton A Novel Topology and Redox Regulation of the Rat Brain K+-dependent Na+/Ca2+ Exchanger, NCKX2 J. Biol. Chem., December 6, 2002; 277(50): 48923 - 48930. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||